Search Results - "Haddad, Tarik J."

A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis by Parker, Joseph M, Glaspole, Ian N, Lancaster, Lisa H, Haddad, Tarik J, She, Dewei, Roseti, Stephanie L, Fiening, Jon P, Grant, Ethan P, Kell, Chris M, Flaherty, Kevin R

“…IL-13 is a potential therapeutic target for idiopathic pulmonary fibrosis (IPF); preclinical data suggest a role in tissue fibrosis, and expression is…”
Get full text

Extracorporeal Liver Support for the Treatment of Hyperammonemia After Lung Transplantation by Kwon, Minkyung, Alvarez, Francisco, Moreno Franco, Pablo, Patel, Alicia, Canabal, Juan M., Haddad, Tarik J., Erasmus, David B., Mallea, Jorge M., Narula, Tathagat

Get full text

Management of Scedosporium apiospermum in a pre- and post-lung transplant patient with cystic fibrosis by Rolfe, Nancy E, Haddad, Tarik J, Wills, Todd S

“…Although the predominant type of infection seen in the cystic fibrosis lung remains bacterial, fungal organisms are being isolated more frequently and are…”
Get full text

Emerging drugs in lung transplantation by Mankidy, Babith, Kesavan, Ramesh B, Silay, Yavuz S, Haddad, Tarik J, Seethamraju, Harish

“…The balance between immunosuppression to ensure graft tolerance while preventing emergence of infectious complications is key in lung transplantation. Although…”
Get more information

Extracorporeal Liver Support for the Treatment of Hyperammonemia After Lung Transplantation by Kwon, Minkyung, Alvarez, Francisco, Moreno Franco, Pablo, Patel, Alicia, Canabal, Juan M, Haddad, Tarik J, Erasmus, David B, Mallea, Jorge M, Narula, Tathagat

Get full text